HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

Abstract
To determine the relationship between cerebral amyloid plaque load and rates of cerebral atrophy in Alzheimer's disease. (11)C-PIB((11)C-6-OH benzothiazole)PET (positron emission tomography) findings were correlated with volumetric magnetic resonance imaging (MRI) measurements in nine subjects with mild to moderate AD. Analysis revealed a positive correlation between rates of whole brain atrophy and whole brain (p = 0.019) and regional (11)C-PIB uptake. This provides support for the central role of amyloid deposition in the pathogenesis of AD.
AuthorsHilary A Archer, Paul Edison, David J Brooks, Jo Barnes, Chris Frost, Tom Yeatman, Nick C Fox, Martin N Rossor
JournalAnnals of neurology (Ann Neurol) Vol. 60 Issue 1 Pg. 145-7 (Jul 2006) ISSN: 0364-5134 [Print] United States
PMID16802294 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloid
  • Aniline Compounds
  • Carbon Radioisotopes
  • Thiazoles
Topics
  • Aged
  • Alzheimer Disease (diagnostic imaging, metabolism, pathology)
  • Amyloid (metabolism)
  • Aniline Compounds
  • Atrophy
  • Brain (diagnostic imaging, metabolism, pathology)
  • Carbon Radioisotopes
  • Cohort Studies
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography (methods)
  • Thiazoles

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: